Prestige Consumer Healthcare Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare prepares to “lap the effects” of COVID-19 disruption on, estimating its fiscal year 2021 sales will reach $935m, ahead of earlier projections, and maintaining long-term organic growth targets of 2%-3%.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.
Switch consultant Susan Levy suggests drug firms temper enthusiasm for Rx-to-OTC switches with considering the costs NDAs generate and the histories of switches that haven’t been successes.
Prestige Consumer boosted marketing spending 17% in its latest quarter to $40.2m with strategies including viral videos and adding messages to branded e-commerce pages to attract online shoppers. Consumer purchases of products rose 7% in the January-March period.
- OTC, Consumer
- Other Names / Subsidiaries
- Prestige Brands, Inc.